Global University Venturing

Kidney disease-focused drug developer Walden was co-founded by faculty members of Rush University and Harvard University earlier this year.

Oxford's spinout portfolio raised a record-breaking $1.1bn during the past fiscal year and is now 204-companies strong.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

MIT's cancer therapy developer has set terms for an offering that will raise more than $185m if it floats at the top of its range.

10x Genomics has bought Harvard's genetic sequencing system provider and also revealed it closed its purchase of Stockholm University spinout CartaNA.

Ten startups will attend the Digital Forum as part of the university's Startup Challenge in partnership with GCV and Extreme Tech Challenge.

University of Florida's $1m seed fund backed four university spinouts in its inaugural year in sectors including industrial and healthcare.

Imperial's founder-friendly equity scheme has been expanded as part of a wider package of tech transfer reforms.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University endowments have backed a dollar-denominated venture capital fund from M31 Capital, whose earlier investments include Grail.